Biochanin A Alleviates Oxidative Stress in Diabetic Rat Skin
Keywords:
Biochanin A, Diabetes Mellitus, Oxidative Stress, Nrf2 Pathway, SkinAbstract
Background: Diabetes mellitus is a significant global health issue, frequently leading to skin complications exacerbated by chronic hyperglycemia and associated oxidative stress. Oxidative stress, characterized by increased reactive oxygen species (ROS), reduced antioxidant defenses (e.g., Catalase - CAT), and elevated lipid peroxidation (e.g., Malondialdehyde - MDA), plays a critical role in impairing skin integrity in diabetic individuals. The Nrf2/ARE pathway is a key regulator of cellular antioxidant responses. Biochanin A (BCA), a natural isoflavone, possesses known antioxidant properties. This study aimed to evaluate the efficacy of topically applied Biochanin A in mitigating oxidative stress within the skin tissue of streptozotocin (STZ)-induced diabetic rats.
Methods: Diabetes was induced in male Wistar rats using STZ (50 mg/kg, I.P.). Diabetic rats were randomly assigned to receive topical treatment with either a BCA-loaded hydrogel (5% BCA in 1.5% HPMC), vehicle hydrogel (1.5% HPMC), or no treatment for 14 days. A non-diabetic control group was also included. Following the treatment period, skin tissue surrounding a surgical cut was collected. Oxidative stress markers were assessed by measuring MDA levels and CAT activity. The expression of Nrf2 and its downstream target NQO1 was evaluated using immunohistochemistry. Statistical analysis was performed using ANOVA followed by Tukey's post hoc test (p < 0.05).
Results: Compared to the normal control group, untreated diabetic rats showed significantly increased MDA levels and significantly decreased CAT activity, Nrf2 expression, and NQO1 expression in skin tissue. Treatment with BCA significantly reduced MDA levels and significantly increased CAT activity compared to both untreated diabetic and vehicle-treated groups. Furthermore, BCA treatment significantly upregulated the expression of Nrf2 and NQO1 compared to untreated diabetic and vehicle-treated groups. The vehicle group showed minimal effects compared to the untreated diabetic group.
Conclusion: Topical application of Biochanin A effectively mitigates oxidative stress in the skin of diabetic rats. This protective effect appears to be mediated through the enhancement of antioxidant enzyme activity (CAT), reduction of lipid peroxidation (MDA), and activation of the Nrf2/NQO1 signaling pathway. These findings suggest that BCA holds therapeutic potential for managing oxidative stress-associated skin complications in diabetes.
Downloads
Metrics
References
Murphy-Chutorian B, Han G, Cohen SR. Dermatologic Manifestations of Diabetes Mellitus. Endocrinol Metab Clin North Am. 2013 Dec;42(4):869–98.
Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous Manifestations of Diabetes Mellitus. Clinical Diabetes. 2015 Jan 1;33(1):40–8.
Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous Manifestations of Diabetes Mellitus: A Review. Am J Clin Dermatol. 2017 Aug 3;18(4):541–53.
Garg P, Chandra M. Original Research Cutaneous Manifestation of Diabetes mellitus. Journal of Advanced Medical and Dental Sciences Research |Vol [Internet]. 2021; Available from: www.jamdsr.com
Hines A, Alavi A, Davis MDP. Cutaneous Manifestations of Diabetes. Medical Clinics of North America. 2021 Jul;105(4):681–97.
Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. Journal of the European Academy of Dermatology and Venereology. 2012 Oct 20;26(10):1203–11.
Morigny P, Boucher J, Arner P, Langin D. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat Rev Endocrinol. 2021 May 24;17(5):276–95.
Tseng HJ, Chen WC, Kuo TF, Yang G, Feng CS, Chen HM, et al. Pharmacological and mechanistic study of PS1, a Pdia4 inhibitor, in β-cell pathogenesis and diabetes in db/db mice. Cellular and Molecular Life Sciences. 2023 Apr 19;80(4):101.
Caturano A, Rocco M, Tagliaferri G, Piacevole A, Nilo D, Di Lorenzo G, et al. Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications. Antioxidants. 2025 Jan 9;14(1):72.
Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther. 2020 Oct 7;5(1):227.
Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases. 2005 Aug;15(4):316–28.
Deng L, Du C, Song P, Chen T, Rui S, Armstrong DG, et al. The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing. Oxid Med Cell Longev. 2021 Jan 8;2021(1).
Wang G, Yang F, Zhou W, Xiao N, Luo M, Tang Z. The initiation of oxidative stress and therapeutic strategies in wound healing. Biomedicine & Pharmacotherapy. 2023 Jan; 157:114004.
Bellezza I, Giambanco I, Minelli A, Donato R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2018 May;1865(5):721–33.
Wu Q, Shang Y, Shen T, Liu F, Zhang W. Biochanin A protects SH-SY5Y cells against isoflurane-induced neurotoxicity by suppressing oxidative stress and apoptosis. Neurotoxicology. 2021 Sep 1; 86:10–8.
Wu LY, Ye ZN, Zhuang Z, Gao Y, Tang C, Zhou CH, et al. Biochanin a reduces inflammatory injury and neuronal apoptosis following subarachnoid hemorrhage via suppression of the TLRs/TIRAP/MyD88/NF-κB pathway. Behavioural Neurology. 2018;2018.
Sarfraz A, Javeed M, Shah MA, Hussain G, Shafiq N, Sarfraz I, et al. Biochanin A: A novel bioactive multifunctional compound from nature. Science of The Total Environment. 2020 Jun 20; 722:137907.
Vâță D, Stanciu DE, Temelie-Olinici D, Porumb-Andrese E, Tarcău BM, Grecu VB, et al. Cutaneous Manifestations Associated with Diabetes Mellitus—A Retrospective Study. Diseases. 2023 Aug 18;11(3):106.
Chen X, Xie N, Feng L, Huang Y, Wu Y, Zhu H, et al. Oxidative stress in diabetes mellitus and its complications: From pathophysiology to therapeutic strategies. Chin Med J (Engl). 2025 Jan 5;138(1):15–27.
Sadri H, Goodarzi MT, Salemi Z, Seifi M. Antioxidant effects of Biochanin a in streptozotocin induced diabetic rats. Brazilian Archives of Biology and Technology. 2017;60.
Ebaid H, Bashandy SAE, Alhazza IM, Hassan I, Al-Tamimi J. Efficacy of a Methanolic Extract of Adansonia digitata Leaf in Alleviating Hyperglycemia, Hyperlipidemia, and Oxidative Stress of Diabetic Rats. Biomed Res Int. 2019 Mar 7; 2019:1–10.
Morales M, Munné-Bosch S. Malondialdehyde: Facts and Artifacts. Plant Physiol. 2019 Jul 28;180(3):1246–50.
Mohan Kumar KM, Bobby Z, Selvaraj N, Kumar Das A, Chandra Koner B, Sen SK, et al. Possible link between glycated hemoglobin and lipid peroxidation in hyperthyroidism. Clinica Chimica Acta. 2004 Apr;342(1–2):187–92.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
